Latest News and Seminars
Department Expands Training For Students With Industrial Career Interest
The department is actively engaged in promoting research internships and co-op opportunities within pharmaceutical companies for students who are considering an industrial career. Approved companies include Pfizer, Merck, Novartis, and others providing local, regional and global research training opportunities
NIH Awards Team of U of R Scientists $9 Million to Study Immune System in Action
Since the early days of Kodak, Xerox, and Bausch & Lomb, Rochester-area innovators have been making astounding discoveries in optics and imaging. Researchers at the University of Rochester are beginning a major study that will add to the region's imaging expertise, while also advancing global understanding of how the body's immune system works.
The National Institutes of Health (NIH) has awarded a five-year, $9 million Research Program Project Grant (PO1) to scientists in the School of Medicine and Dentistry to adapt and develop cutting-edge imaging techniques, allowing them to view the immune system while it is fighting infection and disease.Read the full story on URMC Newsroom
Anisha Gundewar Receives 2014-15 Fulbright U.S. Student Grant Award
Anisha Gundewar (B.S., Class of 2014) was awarded a 2014-15 Fulbright U.S. Student Grant. This fall, Anisha, will pursue an independent research project in India through the 2014-15 Fulbright U.S. Student Grant program.
Read the full story on University of Rochester News
Microbiology & Immunology Class of 2014 Commencement
Commencement was held for the Department of Microbiology & Immunology's Ph.D., Masters and Bachelors programs the weekend of May 17th. Congratulations to all of our graduates!
Ph.D. Degree Awarded: Sarah Amie, Waaqua Daddacha, Nan Deng , William Domm, Anthony Gaca, Joanne Lim, John Muchiri , Akeisha Sanders, Jacqueline Tung
Masters Degree Awarded: Anna Bird, Matthew Brewer, Anthony DiPiazza, Alison Gaylo, Kun Hyoe Rhoo, Letitia Jones, Dillon Schrock, Jason Sifkarovski, Madeline Sofia, Zhuo-Qian Zhang
BS/MS Program: Maksym Marek, Alexander Wei
Bachelors Program: Woori Bae, Robert Bortz, Natasha Chainani, Amanda Chan, Phillip Cohen, Hillary Figler, Anisha Gundewar, Zachariah Hale, Saad Ali Khan, Beom Soo Kim, Justin Kim, Soyeon Kim, Yo-El Kim, Kevin Koenders, Fang Liu, Clare C. Ma, Abhiniti Mittal, Bryan Myers, Ugochi Ndubuisi, Joo-Eun Park, Valerie Pietroluongo, Prishanya Pillai, Priyanka Pillai, Patrick Schupp, Vaidehi Shah, Meng-Ju Wu, Isabel Wylie
Rochester Researchers Receive $3 Million to Study Flu
Researchers at the University of Rochester School of Medicine and Dentistry were awarded approximately $3 million from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health to continue the work being performed by the New York Influenza Center of Excellence (NYICE).
Researchers Awarded $3.5 Million in NYS Stem Cell Grants
Six scientists from the University of Rochester School of Medicine and Dentistry have been recommended awards of more than $3.5 million by NYSTEM. The grants are for a wide range of research programs in the fields of neurological disorders, bone growth and repair, and cancer.
Friday, July 18, 2014 from 10:00-11:00 AM in the Ryan Case Method Room(1-9576)Christine Malboeuf, Ph.D. Research Scientist II Broad Institute of MIT & Harvard University
Title: Development of Univerisal Methods for High Throughput Sequencing of Viral RNA Genomes
Dr. Malboeuf received her Ph.D. from the Department of Microbiology & Immunology in the laboratory of Robert Rose, Ph.D.
Seminar Abstract: Standard methods for sequencing and assembly of viral RNA genomes are virus-specific, relying on prior knowledge to develop sequence-specific primers, and thus are biased towards known variants. They require significant development time for each viral type and cannot be employed if the viral agent is unknown or not well-characterized. Our goal is to develop a universal method for all RNA virus samples that will greatly simplify lab processes, eliminate biases and remove the need for development effort for specific viruses or subtypes.
To address this challenge, we developed universal, sequence-independent RNA-Seq protocols coupled with novel de novo assembly methods optimized for viral genomes. These unbiased methods are scalable and can generate full genomes from diverse samples, even in the presence of substantial amounts of host RNA. To date we have processed >2,000 clinical samples from respiratory syncytial, Lassa, dengue and West Nile virus using our generic approach for all sample types.